What you should know:
1. Lumenis creates medical devices for aesthetics, urology, ophthalmology, ENT and gynecology.
2. Lumenis has a corporate presence in more than 100 countries and close to 1,500 worldwide employees. The company has its strongest presence in the Asia Pacific market, but is established in North America and Europe as well.
3. The companies expect to close the transaction in early 2020.
Lumenis CEO Tzipi Ozer-Armon said, “I would like to thank the entire Lumenis team, I am truly proud of all we have accomplished and honored to lead a company on the cutting edge of healthcare innovation, committed to improving the lives of people across the world.”
More articles on surgery centers:
ASCs in Texas, Michigan, Tennessee closed this year
Indiana investor acquires $24M of medical office buildings, some with surgery centers in 4 states
New York surgery center reopens 1+ year after fire — 3 insights
